262 related articles for article (PubMed ID: 16170379)
61. Increasing methylation of the calcitonin gene during disease progression in sequential samples from CML patients.
Mills KI; Guinn BA; Walsh VA; Burnett AK
Leuk Res; 1996 Sep; 20(9):771-5. PubMed ID: 8947587
[TBL] [Abstract][Full Text] [Related]
62. [Methylation of miR-378 in Chronic Myeloid Leukemia].
Wu DH; Yang J; Yang L; Wen XM; Guo H; Yao DM; Lin J; Zhang YY; Zhang M; Deng ZQ; Qian J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):61-5. PubMed ID: 26913395
[TBL] [Abstract][Full Text] [Related]
63. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer.
Daskalos A; Nikolaidis G; Xinarianos G; Savvari P; Cassidy A; Zakopoulou R; Kotsinas A; Gorgoulis V; Field JK; Liloglou T
Int J Cancer; 2009 Jan; 124(1):81-7. PubMed ID: 18823011
[TBL] [Abstract][Full Text] [Related]
64. Long: molecular tracking of CML with bilineal inv(16) myeloid and del(9) lymphoid blast crisis and durable response to CD19-directed CAR-T therapy.
Venkataraman V; Casey KS; Onozato M; Cin PD; Nardi V; Amrein PC; Bergeron MK; Brunner AM; Fathi AT; Foster JE; Moran J; Graubert TA; Hock H; Hunnewell C; Frigault MJ; McAfee S; Hobbs GS
Leukemia; 2020 Nov; 34(11):3050-3054. PubMed ID: 32678290
[No Abstract] [Full Text] [Related]
65. Genome-wide characterization of human L1 antisense promoter-driven transcripts.
Criscione SW; Theodosakis N; Micevic G; Cornish TC; Burns KH; Neretti N; Rodić N
BMC Genomics; 2016 Jun; 17():463. PubMed ID: 27301971
[TBL] [Abstract][Full Text] [Related]
66. DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells.
Li Y; Liu X; Guo X; Liu X; Luo J
Leuk Res; 2017 Jul; 58():9-13. PubMed ID: 28376405
[TBL] [Abstract][Full Text] [Related]
67. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
[TBL] [Abstract][Full Text] [Related]
68. Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells.
Cheng L; Tang Y; Chen X; Zhao L; Liu S; Ma Y; Wang N; Zhou K; Zhou J; Zhou M
Cancer Biol Ther; 2018 Aug; 19(8):676-686. PubMed ID: 29565710
[TBL] [Abstract][Full Text] [Related]
69. Abl interconnects oncogenic Met and p53 core pathways in cancer cells.
Furlan A; Stagni V; Hussain A; Richelme S; Conti F; Prodosmo A; Destro A; Roncalli M; Barilà D; Maina F
Cell Death Differ; 2011 Oct; 18(10):1608-16. PubMed ID: 21455220
[TBL] [Abstract][Full Text] [Related]
70. The expression of LINE1-MET chimeric transcript identifies a subgroup of aggressive breast cancers.
Miglio U; Berrino E; Panero M; Ferrero G; Coscujuela Tarrero L; Miano V; Dell'Aglio C; Sarotto I; Annaratone L; Marchiò C; Comoglio PM; De Bortoli M; Pasini B; Venesio T; Sapino A
Int J Cancer; 2018 Dec; 143(11):2838-2848. PubMed ID: 30144023
[TBL] [Abstract][Full Text] [Related]
71. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia.
Liu TC; Lin SF; Chang JG; Yang MY; Hung SY; Chang CS
Br J Haematol; 2003 Nov; 123(4):654-61. PubMed ID: 14616969
[TBL] [Abstract][Full Text] [Related]
72. Discovery of somatic mutations in the progression of chronic myeloid leukemia by whole-exome sequencing.
Huang Y; Zheng J; Hu JD; Wu YA; Zheng XY; Liu TB; Chen FL
Genet Mol Res; 2014 Feb; 13(1):945-53. PubMed ID: 24634115
[TBL] [Abstract][Full Text] [Related]
73. p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia.
Guinn BA; Mills KI
Leuk Lymphoma; 1997 Jul; 26(3-4):211-26. PubMed ID: 9322884
[TBL] [Abstract][Full Text] [Related]
74. Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance.
Issa JP; Kantarjian H; Mohan A; O'Brien S; Cortes J; Pierce S; Talpaz M
Blood; 1999 Mar; 93(6):2075-80. PubMed ID: 10068681
[TBL] [Abstract][Full Text] [Related]
75. Aberrant DNA methylation of PTPRG as one possible mechanism of its under-expression in CML patients in the State of Qatar.
Ismail MA; Samara M; Al Sayab A; Alsharshani M; Yassin MA; Varadharaj G; Vezzalini M; Tomasello L; Monne M; Morsi H; Qoronfleh MW; Zayed H; Cook R; Sorio C; Modjtahedi H; Al-Dewik NI
Mol Genet Genomic Med; 2020 Oct; 8(10):e1319. PubMed ID: 32700424
[TBL] [Abstract][Full Text] [Related]
76. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.
Wolff EM; Byun HM; Han HF; Sharma S; Nichols PW; Siegmund KD; Yang AS; Jones PA; Liang G
PLoS Genet; 2010 Apr; 6(4):e1000917. PubMed ID: 20421991
[TBL] [Abstract][Full Text] [Related]
77. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response.
Behzad MM; Shahrabi S; Jaseb K; Bertacchini J; Ketabchi N; Saki N
Biochem Genet; 2018 Jun; 56(3):149-175. PubMed ID: 29388070
[TBL] [Abstract][Full Text] [Related]
78. [Preliminary study of proteins related to blast crisis in chronic myeloid leukemia].
Zhu HQ; Liu XL; Li R; Du QF; Zhang S; Yao F; Liu Z
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):655-9. PubMed ID: 20021859
[TBL] [Abstract][Full Text] [Related]
79. Tissue-Specific Methylation of Long Interspersed Nucleotide Element-1 of Homo Sapiens (L1Hs) During Human Embryogenesis and Roles in Neural Tube Defects.
Wang L; Chang S; Guan J; Shangguan S; Lu X; Wang Z; Wu L; Zou J; Zhao H; Bao Y; Qiu Z; Niu B; Zhang T
Curr Mol Med; 2015; 15(5):497-507. PubMed ID: 26122653
[TBL] [Abstract][Full Text] [Related]
80. Long Interspersed Nuclear Elements 1 (LINE1): The chimeric transcript L1-MET and its involvement in cancer.
Cervantes-Ayalc A; Ruiz Esparza-Garrido R; Velázquez-Flores MÁ
Cancer Genet; 2020 Feb; 241():1-11. PubMed ID: 31918342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
